Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-27

FDA Approved: TADALAFIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Tadalafil submitted by Aurobindo Pharma Limited. This action adds regulatory approval for the tadalafil product …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)